Clinical trial
Safety Study of Tetrathiomolybdate in Patients With Idiopathic Pulmonary…
NCT00189176 · University of Michigan, Other · Completed
Key facts
| NCT number | NCT00189176 |
|---|---|
| Title | Safety Study of Tetrathiomolybdate in Patients With Idiopathic Pulmonary Fibrosis |
| Official title | Phase I/II Trial of Tetrathiomolybdate (TM) in Patients With Usual Interstitial Pneumonia Refractory to Previous Therapy |
| Lead sponsor | University of Michigan, Other |
| Collaborators | Coalition for Pulmonary Fibrosis |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Idiopathic Pulmonary Fibrosis |
| Intervention type | Drug |
| Interventions | Tetrathiomolybdate |
| Enrollment | 23 |
| Start date | Mar 1, 2003 |
| Primary completion | May 1, 2006 |
| Completion | May 1, 2006 |
| First posted | Sep 16, 2005 |
| Last update posted | Feb 6, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: